Actuate Beats on Q3 Loss Per Share but Cash Falls to $2.1M With Going-Concern Doubt
ACTU is trading near its 52-week low of $0.283 (0.8% above the low).
Summary
Actuate posted a Q3 adjusted loss of 14 cents a share, better than the 17-cent loss three analysts expected, on zero revenue as anticipated. The reported net loss was $3.42 million. The beat is cosmetic: the company closed the quarter with $2.1 million in cash and explicit going-concern doubt, leaning on the October offering that netted $11.76 million after the over-allotment was exercised November 13. That capital raise came at $0.71 per two shares plus a warrant, and the stock has since slid to about $0.29 — down 62% this quarter and 95.2% this year — leaving it under a Nasdaq minimum bid price notice received October 28 with until April 26, 2027 to regain compliance. The analyst consensus remains 'buy' with a $12 median target, but that rating predates the dilution and the collapse in the share price.
At the time of this announcement, ACTU was trading at $0.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.7M. The 52-week trading range was $0.28 to $7.90. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.